Steven Cohen’s Centessa Pharmaceuticals CNTA Stock Holding History

Steven Cohen’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,900	Closed	-$234K	–	4085
2026 Q1	$234K	Buy	+5,900	New	+$151K	﹤0.01%	3458

Steven Cohen's CNTA Position: Q2 2026 in Review

Steven Cohen sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 307,355 shares — an estimated $12.2M sold.

Steven Cohen first reported a position in CNTA in Q2 2021 and held it in 19 quarters. The position peaked at $57.4M in Q4 2024. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Steven Cohen reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 307,355 Centessa Pharmaceuticals shares in Q2 2026, an estimated $12.2M.
Steven Cohen first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 19 quarters.
Steven Cohen's Centessa Pharmaceuticals position peaked at $57.4M in Q4 2024.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.